Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 3 | 5000.00 | 4101.40 | 5910.00 | 5931.50 | 0.9964 | 0.9864 |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 6065.00 | 5931.50 | 1.0225 | 1.0854 | |
| SK-BR-3 | Etoposide | 0.1 | uM | 3 | 5000.00 | 4101.40 | 5421.00 | 5931.50 | 0.9139 | 0.6889 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 3 | 5000.00 | 4101.40 | 6220.00 | 5931.50 | 1.0486 | 1.1867 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 3 | 5000.00 | 4101.40 | 6027.00 | 5931.50 | 1.0161 | 1.0609 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 3 | 5000.00 | 4101.40 | 6089.00 | 5931.50 | 1.0266 | 1.1009 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 6009.00 | 5931.50 | 1.0131 | 1.0494 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 3 | 5000.00 | 4101.40 | 5891.00 | 5931.50 | 0.9932 | 0.9744 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 3 | 5000.00 | 4101.40 | 5849.00 | 5931.50 | 0.9861 | 0.9481 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 5853.00 | 5931.50 | 0.9868 | 0.9506 |
| SK-BR-3 | PLX-4720 | 1 | uM | 3 | 5000.00 | 4101.40 | 5985.00 | 5931.50 | 1.0090 | 1.0340 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 5919.00 | 5931.50 | 0.9979 | 0.9921 |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 6018.00 | 5931.50 | 1.0146 | 1.0551 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5943.00 | 5931.50 | 1.0019 | 1.0073 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5541.00 | 5931.50 | 0.9342 | 0.7598 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5857.00 | 5931.50 | 0.9874 | 0.9531 | |
| SK-BR-3 | Etoposide | 0.01 | uM | 3 | 5000.00 | 4101.40 | 6055.00 | 5931.50 | 1.0208 | 1.0789 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 3 | 5000.00 | 4101.40 | 3712.00 | 5931.50 | 0.6258 | -0.1709 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 3 | 5000.00 | 4101.40 | 5894.00 | 5931.50 | 0.9937 | 0.9763 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 3 | 5000.00 | 4101.40 | 6072.00 | 5931.50 | 1.0237 | 1.0899 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 3 | 5000.00 | 4101.40 | 6131.00 | 5931.50 | 1.0336 | 1.1282 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 3 | 5000.00 | 4101.40 | 2711.00 | 5931.50 | 0.4571 | -0.5406 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 3 | 5000.00 | 4101.40 | 5985.00 | 5931.50 | 1.0090 | 1.0340 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 3 | 5000.00 | 4101.40 | 6141.00 | 5931.50 | 1.0353 | 1.1348 |
| SK-BR-3 | Nilotinib | 10 | uM | 3 | 5000.00 | 4101.40 | 2797.00 | 5931.50 | 0.4716 | -0.5128 |